Insulin glargine and lixisenatide and V-COF Suspension
Determining the interaction of Insulin glargine and lixisenatide and V-COF Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: brompheniramine / carbetapentane / phenylephrine
Brand name: BetaTan, Pulmari, VazoTan
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-V-HIST Suspension
- Insulin glargine and lixisenatide-V-Natal Tablets
- Insulin glargine and lixisenatide-Vabomere
- Insulin glargine and lixisenatide-Vabomere (combination)
- Insulin glargine and lixisenatide-Vabomere Injection
- Insulin glargine and lixisenatide-Vaccinia
- V-COF Suspension-Insulin glargine and lixisenatide Subcutaneous
- V-COF Suspension-Insulin glargine, recombinant Subcutaneous
- V-COF Suspension-Insulin glulisine
- V-COF Suspension-Insulin Glulisine (Cartridges and Pens)
- V-COF Suspension-Insulin Glulisine (Vials)
- V-COF Suspension-Insulin glulisine Subcutaneous